ALXN stock: buy or sell
Jul 29th, 2021
ALXN stock brief
- Alexion Pharmaceuticals closed on July 20 at $182.50 (1.70%) prior to reporting earnings next October at 08:00
- The stock is configuring an uptrend pattern since last March, when it bottomed at $146.97. Up to date, price made a 24.18% profit since the beginning of this rally
- Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products.
Should I buy Alexion Pharmaceuticals stock?
All successful traders recommend adhering to a trading strategy and not make decisions based on subjective opinions, rumors or feelings. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best
Is $ALXN stock a buy?
In the current situation of Alexion Pharmaceuticals there is not any eligible buy setup. This doesn't mean we expect a selloff for $ALXN in coming sessions, or that it may not rise higher. Simply, it doesn't match our recommended trading systems
Should I sell Alexion Pharmaceuticals stock?
When you are a novel trader and you own a stock with some profit, it's really hard to decide the good moment to sell and get your profits. As when we have to buy shares, determining when is appropiate time to sell is not a whimsy decision, and we must adhere our own trading strategy. When selling, as well as buying, our strategies are very easy to use but are only valid for selling stocks in your porfolio, not for shorting $ALXN stock
As a rule of thumb, you should never keep an investment that yields higher than expected losses at the time of the buy. The moment to sell your stock must always be ruled by the stop-loss (automatic or manual)
Is it time to sell Alexion Pharmaceuticals stock?
In the current situation of Alexion Pharmaceuticals there is not any eligible sell setup, so Alexion Pharmaceuticals stock holders with operations in green can keep their positions
Alexion Pharmaceuticals ratings
In the previous month we couldn't find any rating for Alexion Pharmaceuticals
Alexion Pharmaceuticals stock analysis
Alexion Pharmaceuticals stock started an uptrend last March, and gained a gorgeous 24.18%. The price action shows rising tops and bottoms, and along the way provided very few entry points for those who wanted to invest. Latest pullback was in early June, when price bounced at $174.72. Like in all uptrends, price needs to rest and currently price is moving in a range between $187.45 and $174.72
Supports and resistances
The current resistance levels are:
The current supports are:
The price is trading very close to the upper Bollinger band, signaling some level of overbought in recent sessions. This is not a bearish indicator, as price can trade in these levels for many days and weeks. The price is moving near to the lower Bollinger band, poiting some level of oversold in recent sessions. This is not a bullish indicator, as price can move in these levels for many days and weeks
Relative strength index
The RSI dropped below the overbought level of 70 on July 6 after just crossing to the overbough zone for just one day (weak signal). The RSI reading on July 20 was 52.18. Alexion Pharmaceuticals stock fell a 2.03% since RSI lost the overbought zone
Alexion Pharmaceuticals stock price history
Alexion Pharmaceuticals went public on Feb 28th, 1996 at $2.28 per share1. Since then, ALXN stock surged by 7,904.39%, with an average of 316.18% per year. An investment of $1,000USD on the IPO would worth $80,043.86 today.
1: Adjusted price after possible price splits or reverse-splits
Price target for Alexion Pharmaceuticals stock
How much a stock will be priced tomorrow or next week is quite unpredictable. Banks and financial organisations issue their analysis predicting how a particular stock will performance in the future.
Along with buy or sell recommendations, financial institutions publish their price target based on the stock price action and the company fundamental data. Most of these predictions follow the publication of new fundamental information by the company, and usually. Again, these estimates are not direct recommendations for small traders and must not be trusted blindly.
In the last month we couldn't find any price target published for Alexion Pharmaceuticals stock.
Earnings and financials
Alexion Pharmaceuticals performance
|Alexion Pharmaceuticals ($ALXN)||1.10%||8.80%||14.70%|
Please read:The opinions expressed in this article are personal and should not be followed as recommendations for you to buy or sell stocks. The author of this text does not know the individual circumstances of the reader, his or her finances or what is in his or her best interest at any given time. All users should speak with their financial advisor before buying or selling any securities Viewpoints are posted for educative motives only
|Tuesday, July 20th, 2021|
|Day range||$180.13 - $182.67|
|Average true range||$2.97|
|50d mov avg||$179.49|
|100d mov avg||$168.40|
|200d mov avg||$153.59|
|Earnings date||October 27th, 2021|